NASDAQ
17.09.26 | 15:31
5,990 US-Dollar
+2,74 % +0,160
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.09. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.09. | Profound Medical Corp (2): Profound Medical appoints Fabian as president | 1 | Stockwatch | ||
| 18.08. | Profound Medical Corp (2): Profound introduces software for six Tulsa procedures | 1 | Stockwatch | ||
| 17.08. | Profound Medical Corp.: Profound's Introduction of New Real-time Interventional MRI Software Paving the Way for Full 'TULSA Days' | 1 | GlobeNewswire (USA) | ||
| 15.08. | Profound Medical Corp (2): Profound Medical appoints Sobczyk interim CFO | 1 | Stockwatch | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 14.08. | Profound Medical names interim CFO | 1 | Seeking Alpha | ||
| 14.08. | Profound Medical Corp.: Profound Medical Announces Management Change | 224 | GlobeNewswire (Europe) | TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets innovative... ► Artikel lesen | |
| 13.08. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.08. | Profound Medical Corp.: Profound Medical Launches 'Let's Huddle', a Global Community Supporting Men Throughout Their Prostate Care Journey | 1 | GlobeNewswire (USA) | ||
| 06.08. | Profound Medical GAAP EPS of -$0.26 misses by $0.02, revenue of $2.5M misses by $2.19M | 1 | Seeking Alpha | ||
| 06.08. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.08. | Profound Medical Corp.: Profound Medical Reports Second Quarter 2026 Financial Results | 195 | GlobeNewswire (Europe) | - Operating expenses decline 16%, helping drive a 39% improvement in net loss - - Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing - - Strong clinical... ► Artikel lesen | |
| 27.07. | Profound Medical: Aktie nach Studiendaten und Erstattungsausblick auf "Strong Buy" hochgestuft | 1 | Investing.com Deutsch | ||
| 27.07. | Profound Medical stock upgraded to Strong Buy on trial data, reimbursement outlook | 1 | Investing.com | ||
| 24.07. | Profound Medical Corp (2): Profound finds no penile length change after Tulsa | 1 | Stockwatch | ||
| 24.07. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 24.07. | Profound Medical Corp.: Robotic Radical Prostatectomy Comes Up 'Short' in CAPTAIN Trial | 4 | GlobeNewswire (USA) | ||
| 17.07. | Profound Medical Corp (2): Profound Medical to release Q2 results on Aug. 6 | 1 | Stockwatch | ||
| 15.07. | Stocks in Play: Profound Medical Corp. | - | Baystreet.ca | ||
| 15.07. | Profound Medical Corp. - 8-K, Current Report | 2 | SEC Filings |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,614 | +0,07 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,068 | +5,56 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| CERENOME | 1,680 | -4,65 % | Cerenome, Inc.: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division | HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announces the appointment of Samantha... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,140 | +1,90 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | -2,61 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,981 | +4,27 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 9,278 | +1,82 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,390 | +3,02 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| LIFEWARD | 6,910 | 0,00 % | Lifeward legt Termin für jährliche und außerordentliche Hauptversammlung 2026 fest | ||
| CLOVER HEALTH INVESTMENTS | 3,940 | -0,76 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| SENSEONICS | 7,850 | -0,63 % | Senseonics sees activist investor take a major stake | ||
| TEMPEST THERAPEUTICS | 0,921 | -23,87 % | Tempest Therapeutics: Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform | -Transaction complements Tempest's existing CD7-targeted lipid nanoparticle in vivo CAR-T delivery platform, which is planned to enter the clinic later this year -Lead BCMA/GPRC5D dual-targeting in... ► Artikel lesen | |
| NANO-X IMAGING | 0,760 | +0,85 % | Nano-X Imaging Ltd: Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica | Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative... ► Artikel lesen | |
| IMUNON | 1,230 | -1,60 % | Imunon, Inc.: IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001 |
Das Unternehmen PROFOUND MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 5,990 Euro und damit +2,74 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.